Corresponding Responsibility - Mpje

1. What is the correct response when a pharmacist believes dispensing would be unsafe despite a valid prescription?

   Use professional judgment to withhold and consult prescriber for changes. Professional judgment allows withholding unsafe prescriptions, even if valid, to prioritize patient safety under ethical duties.

2. What is the pharmacist's corresponding responsibility when the prescriber is known for improper prescribing patterns?

   Apply heightened scrutiny and verify legitimacy for each prescription. Known improper prescribers increase diversion likelihood, requiring per-prescription scrutiny to ensure legitimacy.

3. What is the pharmacist's duty when the prescriber's identity or DEA registration is questionable?

   Verify prescriber identity/authority before dispensing; otherwise refuse. Questionable prescriber credentials raise diversion risks, necessitating verification to fulfill corresponding responsibility obligations.

4. Identify the best action when a prescriber refuses to provide diagnosis or justification for a high-risk regimen.

   Refuse to fill due to inability to verify legitimate medical purpose. Prescriber non-cooperation hinders verification, requiring refusal to ensure compliance with legitimate purpose mandates.

5. Identify the action when multiple prescribers are used for similar controlled substances without explanation.

   Check PDMP and verify with prescriber(s); refuse if unresolved. Multiple prescribers without rationale suggest doctor shopping, mandating PDMP review and resolution to ensure legitimate use.

6. What is the appropriate action if red flags remain after reasonable verification attempts?

   Refuse to fill because legitimacy cannot be established. Unresolved red flags imply failure to establish legitimacy, necessitating refusal to prevent illegal dispensing under federal law.

7. Which action is required when the patient's story conflicts with the prescription or medical history on file?

   Investigate and verify with prescriber/records before dispensing. Conflicting patient information suggests possible fraud, so investigation ensures the prescription aligns with verified medical needs.

8. Identify the correct action when a controlled substance prescription appears legitimate but is outside pharmacy policy limits.

   Apply policy if lawful; ensure patient care and refer appropriately. Pharmacy policies can impose stricter limits than law, but must balance with patient needs and appropriate referrals.

9. What must a pharmacist do if a prescription directions are ambiguous and could cause patient harm?

   Clarify with prescriber before dispensing; document the clarification. Ambiguous directions risk misinterpretation and harm, so clarification ensures safe dispensing under professional judgment duties.

10. Which response is appropriate when the diagnosis and drug choice appear clinically inconsistent or unsafe?

    Contact prescriber to clarify/resolve; do not dispense until resolved. Inconsistent diagnosis-drug pairings pose safety risks, requiring prescriber clarification to meet therapeutic appropriateness standards.

11. Which practitioner standard triggers corresponding responsibility under federal controlled substance rules?

    The prescription must be in the usual course of professional practice. Federal rules require prescriptions to align with professional standards to prevent diversion and ensure patient safety.

12. Which action is required when a patient presents an unusually early refill request for a controlled substance?

    Assess for red flags and verify clinical rationale before dispensing. Early refills may signal abuse or diversion, prompting pharmacists to evaluate and confirm medical necessity per federal guidelines.

13. What is the pharmacist's responsibility for documenting resolution of controlled substance red flags?

    Document verification steps and rationale supporting the dispensing decision. Documentation provides evidence of due diligence, protecting pharmacists from liability in corresponding responsibility enforcement.

14. Which option best describes a "red flag" in corresponding responsibility analysis?

    A fact pattern suggesting diversion or lack of legitimate medical purpose. Red flags indicate potential non-medical use, triggering heightened scrutiny to uphold corresponding responsibility requirements.

15. Identify the best action when a controlled substance prescription is for a patient not previously seen and multiple red flags exist.

    Perform heightened verification (PDMP, prescriber contact); refuse if unresolved. New patients with red flags warrant extra checks to mitigate diversion risks and fulfill verification responsibilities.

16. What does the pharmacist's corresponding responsibility require before dispensing any prescription?

    Ensure the prescription is issued for a legitimate medical purpose. Pharmacists share responsibility with prescribers to confirm that controlled substance prescriptions meet federal legitimacy standards before dispensing.

17. What is the appropriate response when a patient insists on paying cash for high-dose opioids despite insurance?

    Treat as a red flag; verify legitimacy with prescriber and records. Cash payments for high-risk drugs can indicate avoidance of tracking, requiring legitimacy checks to comply with anti-diversion responsibilities.

18. What is the pharmacist's duty when a controlled substance prescription is presented outside normal clinic hours repeatedly?

    Treat as a red flag; verify legitimacy and pattern before dispensing. Repeated off-hours presentations may signal evasion, demanding verification to confirm no diversion patterns exist.

19. Identify the best action when a controlled substance prescription has obvious alteration or forgery signs.

    Refuse to fill and initiate verification with the prescriber. Obvious signs of tampering indicate potential illegality, requiring refusal and prescriber contact to avoid liability under controlled substance laws.

20. Which option best states the pharmacist's obligation when refusing to fill a suspicious prescription?

    Refuse to dispense and communicate professionally; document the refusal basis. Refusals must be handled professionally with documentation to justify decisions and maintain regulatory compliance.

21. Identify the correct action when a controlled substance prescription lacks required elements to be valid.

    Do not dispense until corrected by the prescriber per applicable law. Missing elements invalidate the prescription under law, prohibiting dispensing until corrected to avoid regulatory violations.

22. What is the pharmacist's required action when a prescription appears invalid or non-legitimate?

    Refuse to fill until legitimacy is verified; refuse if not verifiable. Corresponding responsibility mandates protecting public health by not dispensing potentially illegitimate or harmful prescriptions without verification.

23. What is the best action when the quantity or strength is extreme without clear clinical justification?

    Verify with prescriber and assess legitimacy; refuse if not justified. Extreme quantities without justification raise abuse concerns, requiring prescriber confirmation to validate medical necessity.

24. What is the pharmacist's responsibility regarding PDMP information when red flags are present?

    Review PDMP as part of due diligence and resolve discrepancies. PDMP data helps identify patterns of abuse, making its review essential for resolving red flags in controlled substance dispensing.

25. What is the best action when a controlled substance prescription is from a distant prescriber with no local rationale?

    Evaluate red flags and verify medical purpose before dispensing. Distant prescribers without justification may imply diversion, so red flag assessment ensures prescriptions serve valid medical purposes.

Study these flashcards